Brief: PCI Biotech Holding Q1 Operating Loss Narrows To NOK 6.4 Mln
May 12 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q1 OPERATING LOSS NOK 6.4 MILLION VERSUS LOSS NOK 22.8
MILLION
YEAR AGO
* CASH POSITION OF NOK 51 MILLION ENABLES A FINANCIAL RUNWAY
TOWARDS THE END OF 2024 WITH CURRENT PLANS
Source text for Eikon: ID:nGNE9Qnrkv
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process